Overview

Trial of the Effectiveness of AQ/AS, SP/AQ and SP/CQ for Uncomplicated Malaria in Gambian Children

Status:
Completed
Trial end date:
2004-02-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this trial is to compare the effectiveness of three combination treatments for uncomplicated malaria when given in operational settings, without supervision of doses other than the first dose.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
London School of Hygiene and Tropical Medicine
Collaborators:
Medical Research Council
National Malaria Control Programme, The Gambia
Treatments:
Amodiaquine
Artesunate
Chloroquine
Chloroquine diphosphate
Fanasil, pyrimethamine drug combination
Pyrimethamine
Sulfadoxine
Criteria
Inclusion Criteria:

- Presentation at health centre with febrile illness

- Monoinfection with P. falciparum

- Parasitaemia >=500/microlitre

- Fever or history of fever

Exclusion Criteria:

- Signs of severe or complicated malaria (persistent vomiting with or without
dehydration, history of convulsion during the present illness, inability to sit or
stand, parasitaemia >200,000/ul)

- Severe malnutrition

- Clinically evident concomitant disease

- PCV <20%

- History of allergy to the study medications

- Residence outside the study area and hence difficult to follow up